HCPCS code J9150: Daunorubicin injection, per 10 mg2026 Medicare rate & RVUs in Illinois
Reports daunorubicin supplied for antineoplastic treatment, with each HCPCS unit representing 10 mg of the drug administered to the patient.
CMS doesn’t publish an office rate for J9150 in Illinois.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J9150 covers
Daunorubicin is an anthracycline antineoplastic drug used in chemotherapy, including treatment of acute leukemias. Hematology and oncology teams administer it by intravenous injection, commonly as part of a multi-drug treatment regimen in a hospital or infusion setting. The drug code identifies the daunorubicin supplied; the service used to administer chemotherapy is coded separately when appropriate.
J9150 is a Part B drug code with a 10 mg billing unit. Count units by dividing the documented amount of daunorubicin administered by 10 mg. CMS excludes the code from the physician fee schedule under status E; when Medicare covers the item, payment is made under another method. CMS assigns it Part B drug pricing, generally using the quarterly Average Sales Price drug pricing files when covered. Special Medicare coverage instructions apply.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J9150 pays more and less in Illinois
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
| Payment locality | Office | Facility |
|---|---|---|
| Chicago, IL | Unavailable | Unavailable |
| East St. Louis, IL | Unavailable | Unavailable |
| Rest of Illinois | Unavailable | Unavailable |
| Suburban Chicago, IL | Unavailable | Unavailable |
How the J9150 rate is calculated
Each of J9150’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J9150
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J9150
J9150 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J9150
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J9150 isn’t priced in this setting.
J9150 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J9153Daunorubicin/cytarabinePer 1 mg daunorubicin
- J9153 identifies a combination product containing daunorubicin and cytarabine. J9150 is for daunorubicin alone.
- J9000Doxorubicin injectionPer 10 mg
- J9000 identifies doxorubicin, a different anthracycline drug. Use the code for the drug actually supplied.
- J9120DactinomycinPer 0.5 mg
- J9120 identifies dactinomycin, not daunorubicin. These are distinct antineoplastic drugs.
J9150 billing questions
How many units should be reported?
Each unit represents 10 mg of daunorubicin. Calculate units from the documented amount administered.
How is J9150 different from J9153?
J9150 represents daunorubicin alone. J9153 represents a daunorubicin-and-cytarabine combination product, so select the code matching the product administered.
Does J9150 include chemotherapy administration?
No. J9150 identifies the drug; report the applicable chemotherapy administration service separately when it is performed and separately reportable.
How does Medicare price this code?
CMS excludes J9150 from the physician fee schedule under status E. When Medicare covers it, the code is treated as a Part B drug and generally priced using CMS quarterly ASP drug pricing files.
What should the record support?
Document the daunorubicin product and the amount administered so the reported 10 mg units can be supported.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J9150 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist